Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
Anticoagulation with a mitral valve mechanical replacement
Wednesday 30 August 2017, 02:57 PM
The ECG shows atrial fibrillation, a normal axis and a heart rate of 86 beats/minute, without other significant changes
A working mother visits for a medications review. Cardiologist Chris Ellis explains her INR test result, her anticoagulation and the need for well-funded rheumatic fever prevention strategies
A 46-year-old New Zealand-born female of Samoan ethnicity comes in for a review and her normal prescription. She takes warfarin 6mg, diltiazem CD 120m
References
1. Cardiac Society of Australia and New Zealand and the Heart Foundation of New Zealand. The New Zealand guidelines for rheumatic fever: 2014 update. Available at www.heartfoundation.org.nz (100 pages)
2. Woulfe C. Fever pitch. New Zealand Listener, 21 July 2017.